SCHEMBL4386582

SCHEMBL4386582

CC(C)COC(=O)N1CCN(c2cccc3cc(S(=O)(=O)c4cccc(F)c4)cnc23)CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 4/20 0.67
HTR2A P28223 3/20 0.67
HTR1A P08908 2/20 0.48
DRD2 P14416 2/20 0.48
HTR7 P34969 1/20 0.48
MAPT P10636 4/20 0.40
LMNA P02545 3/20 0.40
ALDH1A1 P00352 3/20 0.40
HTT P42858 2/20 0.40
HPGD P15428 2/20 0.40
TSHR P16473 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
CASP1 P29466 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GPR119 Q8TDV5 2/20 0.37
CHRM1 P11229 2/20 0.37
MEN1 O00255 1/20 0.37
GFER P55789 1/20 0.37
KMT2A Q03164 1/20 0.37
CHRM2 P08172 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3204503 0.86 HTR2A (0.71) HTR6HTR2AHTR1ADRD2HTR7
SCHEMBL5758760 0.84 HTR2A (0.48) HTR6HTR2AHTR1ADRD2HTR7
SCHEMBL5757481 0.83 LMNA (0.47) HTR6HTR2AHTR1ADRD2HTR7
SCHEMBL5758622 0.81 HTT (0.44) HTR6HTR2AHTR1ADRD2HTR7
SCHEMBL3132360 0.81 HTR6 (1.00) HTR6HTR2AHTR1ADRD2HTR7
SCHEMBL5757786 0.80 LMNA (0.45) HTR6HTR2AHTR1ADRD2HTR7
SCHEMBL3917828 0.80 MAPT (0.43) HTR6HTR2AHTR1AMAPTLMNA
SCHEMBL5698823 0.79 SMN1; SMN2 (0.41) MAPTLMNAALDH1A1HTTHPGD
SCHEMBL19327101 0.79 HTR2A (0.65) HTR6HTR2AHTR1ADRD2HTR7
SCHEMBL19327037 0.77 HTR6 (0.74) HTR6HTR2AHTR1ADRD2HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2120950-A1 USE OF QUINOLINE DERIVATIVES IN THE TREATMENT OF PAIN AND IRRITABLE BOWEL SYNDROME Glaxo Group Limited (GB) 2009-11-25 EP disclosed
WO-2008113818-A1 USE OF QUINOLINE DERIVATIVES IN THE TREATMENT OF PAIN AND IRRITABLE BOWEL SYNDROME GLAXO GROUP LIMITED (GB) 2008-09-25 WO disclosed